{"name":"VeroScience","slug":"veroscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNUE1DRGY3Z0xhTWJlVVAyNklFOWU5YUNBb1hBS0NOVHA0ZFVTdnlBaEh6TGlDNHpfeTVpU3pzRWFHY0RQal9ZU183cjdVVmZJemJoNWp0bjktbi1DRnJJdVNwVEpZbkR6OTl1OU5zcklhWGEwZGdyQXZDUjlJLWNuN1l6RlE2ZnhfcXl2SEZkSmZkVEhlYWo3Z19aeU90QWZ0MDd5WXNpOUhwQVNYODh3aHd2VjZET3hD?oc=5","date":"2009-05-07","type":"regulatory","source":"Fierce Biotech","summary":"VeroScience Announces FDA Approval of Cycloset for Treatment of Type 2 Diabetes - Fierce Biotech","headline":"VeroScience Announces FDA Approval of Cycloset for Treatment of Type 2 Diabetes","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}